EUVIMEDEUVIMED entdecken
Crossref

Targeting HIF‐1α with Specific DNA Yokes for Effective Anticancer Therapy

Ying Zhang, Bing Wu, Danqing Liu, Yue Chen, Yanfang Xu, Lengxi Fu, Zhenyu Lin, Gui Wu, Fei Huang iD

Advanced Healthcare Materials · 2024

DOI: 10.1002/adhm.202401087 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2024. Verfasst von Ying Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Central Laboratory, Fujian Key Laboratory of Precision Medicine for Cancer, Key Laboratory of Radiation Biology of Fujian Higher Education Institutio…. Hauptthemen laut MEDLINE: Hypoxia-Inducible Factor 1, alpha Subunit, DNA. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: Joint Funds for the Innovation of Science and Technology, Fujian province, Fujian Provincial Health and Health Committee Young and Middle-aged Talents Training Program, First Affiliated Hospital of Fujian Medical University "Excellent Talent Project".

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hypoxia, a ubiquitous hallmark in cancer, underscores the significance of targeting HIF‐1α, the principal transcriptional factor of hypoxic responses, for effective cancer therapy. Herein, DNA yokes, a novel class of DNA nanomaterials harboring specific HIF‐1α binding sequences (hypoxia response elements, HREs), are introduced as nanopharmaceuticals for cancer treatment. Comprising a basal tetrahedral DNA nanostructure and four HRE‐bearing overhanging chains, DNA yokes exhibit exceptional stability and prolonged intracellular retention. The investigation reveals their capacity to bind HIF‐1α, thereby disrupting its interaction with the downstream genomic DNAs and impeding transcriptional activity. Moreover, DNA yokes facilitate HIF‐1α degradation via the ubiquitination pathway, thereby sequestering it from downstream targets and ultimately promoting its degradation. In addition, DNA yokes attenuate cancer cell proliferation, migration, and invasion under hypoxic conditions, while also displaying preferential accumulation within tumors, thereby inhibiting tumor growth and metastasis in vivo. This study pioneers a novel approach to cancer therapy through the development of DNA‐based drugs characterized by high stability and low toxicity to normal cells, positioning DNA yokes as promising candidates for cancer treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hypoxia-Inducible Factor 1, alpha SubunitDNAHumansAnimalsCell Line, TumorMiceNeoplasmsCell ProliferationMice, NudeNanostructuresAntineoplastic AgentsMice, Inbred BALB CCell MovementResponse Elements

Stichwörter der Autor:innen

DNA yokesHIF‐1αanticancer drugscancertetrahedral DNA nanostructures

Substanzen

Hypoxia-Inducible Factor 1, alpha SubunitDNAHIF1A protein, humanAntineoplastic Agents

Autor:innen und Institutionen

  • Central Laboratory, Fujian Key Laboratory of Precision Medicine for Cancer, Key Laboratory of Radiation Biology of Fujian Higher Education Institutions, The First Affiliated Hospital, Fujian Medical University, Fuzhou,…
  • Central Laboratory, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical University, Fuzhou, Fujian, 350212, China.
  • Ministry of Education Key Laboratory for Analytical Science of Food Safety and Biology, Fujian Provincial Key Laboratory of Analysis and Detection for Food Safety, College of Chemistry, Fuzhou University, Fuzhou, Fujian…
  • Department of Orthopaedics, The First Affiliated Hospital, Fujian Medical University, Fuzhou, Fujian, 350005, China.
  • Department of Orthopaedics, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical University, Fuzhou, Fujian, 350212, China.

ORCID-Profile: Fei Huang

Förderung

  • Joint Funds for the Innovation of Science and Technology, Fujian province
  • Fujian Provincial Health and Health Committee Young and Middle-aged Talents Training Program
  • First Affiliated Hospital of Fujian Medical University "Excellent Talent Project"
  • First Affiliated Hospital of Fujian Medical University "Talent Introduction Project"

Zitieren

APA

Zhang, Y., Wu, B., Liu, D., Chen, Y., Xu, Y., Fu, L., Lin, Z., Wu, G., & Huang, F. (2024). Targeting HIF‐1α with Specific DNA Yokes for Effective Anticancer Therapy. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202401087

Vancouver

Zhang Y, Wu B, Liu D, Chen Y, Xu Y, Fu L, et al. Targeting HIF‐1α with Specific DNA Yokes for Effective Anticancer Therapy. Advanced Healthcare Materials. 2024. doi:10.1002/adhm.202401087

BibTeX
@article{Zhang2024,
  author = {Zhang, Ying and Wu, Bing and Liu, Danqing and Chen, Yue and Xu, Yanfang and Fu, Lengxi and Lin, Zhenyu and Wu, Gui and Huang, Fei},
  title = {Targeting HIF‐1α with Specific DNA Yokes for Effective Anticancer Therapy},
  journal = {Advanced Healthcare Materials},
  year = {2024},
  doi = {10.1002/adhm.202401087}
}
Kostenlos starten →